Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Agilon Health (AGL) Non-Current Receivables (2021 - 2022)

Agilon Health's Non-Current Receivables history spans 2 years, with the latest figure at $69.4 million for Q4 2022.

  • For Q4 2022, Non-Current Receivables fell 9.44% year-over-year to $69.4 million; the TTM value through Dec 2022 reached $69.4 million, down 9.44%, while the annual FY2022 figure was $69.4 million, 9.44% down from the prior year.
  • Non-Current Receivables reached $69.4 million in Q4 2022 per AGL's latest filing, down from $76.6 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $76.6 million in Q4 2021 to a low of $69.4 million in Q4 2022.